Fasting apolipoprotein B48 is associated with asymptomatic peripheral arterial disease in type 2 diabetic subjects: A case-control study

Atherosclerosis

Volumn 223, Issue 2, 2012, Pages 504-506

  Lapice, Emanuela ^a   Cipriano, Paola ^a   Patti, Lidia ^a   Romano, Geremia ^a   Vaccaro, Olga ^a   Rivellese, Angela A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Peripheral artery disease; Postprandial metabolism; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN B48; HEMOGLOBIN A1C; LIPID;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; ANKLE BRACHIAL INDEX; APOLIPOPROTEIN B-48; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 84864769124     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.05.038     Document Type: Article

References (14)

1. American Diabetes Association Peripheral arterial disease in people with diabetes. Diabet Care 2003, 26(12):3333-3341.
2. Jude E.B., Eleftheriadou I., Tentolouris N. Peripheral arterial disease in diabetes - a review. Diabet Med 2010, 27:4-14.
3. Aboyans V., McClelland R.L., Allison M.A., et al. Lower extremity peripheral artery disease in the absence of traditional risk factors. The multi-ethnic study of atherosclerosis. Atherosclerosis 2011, 214:169-173.
4. Rivellese A.A., De Natale C., Di Marino L., et al. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J Clin Endocrinol Metab 2004, 89(5):2153-2159.
5. Roche H.M., Gibney M.J. The impact of postprandial lipemia in accelerating atherothrombosis. J Cardiovasc Risk 2000, 7(5):317-324.
6. Valdivielso P., Hidalgo A., Rioja J., et al. Smoking and postprandial triglycerides are associated with vascular disease in patients with type 2 diabetes. Atherosclerosis 2007, 194:391-396.
7. Lupattelli G., Pasqualini L., Siepi D., et al. Increased postprandial lipemia in patients with normolipemic peripheral arterial disease. Am Heart J 2002, 143:733-738.
8. Valdivielso P., Puerta S., Rioja J., et al. Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls. Clin Chim Acta 2010, 411(5-6):433-437.
9. Phillips M.L., Pullinger C., Kroes I., et al. A single copy of apolipoprotein B-48 is present on the human chylomicron remnant. J Lipid Res 1997, 38(6):1170-1177.
10. Smith D., Watts G.F., Dane-Stewart C., Mamo J.C. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state. Eur J Clin Invest 1999, 29(3):204-209.
11. Brown M.L., Ramprasad M.P., Umeda P.K., et al. A macrophage receptor for apolipoprotein B48: cloning, expression, and atherosclerosis. Proc Natl Acad Sci U S A 2000, 97(13):7488-7493. 20.
12. Nakatani K., Sugimoto T., Masuda D., et al. Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels. Atherosclerosis 2011, 7488-7493.
13. Kinoshita M., Kojima M., Matsushima T., Teramoto T. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta 2005, 351:115-120.
14. Brevetti G., Piscione F., Cirillo P., et al. In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction. Atherosclerosis 2008, 201(2):440-446.